AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas

NCT02831257 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Neurofibromatosis 2
Meningioma

Interventions

DRUG: AZD2014

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]